#HealthcareMagazine specialising in Business Information for #Healthcare Professionals. Connecting industry leaders across the healthcare business spectrum
Breast cancer is now the most common cancer worldwide and in India, its burden is rising at an alarming pace. Despite increased awareness, women continue to face delayed diagnosis, fragmented care, and unequal access to treatment. In this authored article, Dr. Tejal Gorasia,
Consultant Breast Expert at Oncolife Cancer Centre, Satara, highlights how artificial intelligence (AI) and innovative care models are beginning to close these gaps and build a more integrated pathway for patients. Head to our website to read more: indiamedtoday.com/ai-and-inn…
In a step towards preventive and digital-first healthcare, Vidal Health (100 per cent subsidiary of Bajaj Finserv Health), India’s second largest TPA service provider and Serum Institute of India (SII), part of Cyrus Poonawalla Group, the world’s largest vaccine manufacturer,
Pharmacists are the bridge between innovation and patient access. On World Pharmacist Day, IndiaMedToday recognises their vital role in medication safety, rational use of drugs, and expanding access in underserved areas. Strengthening the pharmacist’s role in primary care is
Artemis Hospital has inaugurated its cutting-edge Heart and Lung Transplant Centre in Gurugram, designed to provide comprehensive thoracic transplant and mechanical circulatory support services in North India. This advanced facility aims to deliver high-quality transplant care to
Sharp Sight Eye Hospitals, a leading name in eye care in the North and Eastern India, announced the hospital's newest technology in advanced eye care treatments, but more importantly, to celebrate 10 years of service to the people of Kashmir. Head to our website to read more:
The Bulk Drugs Manufacturers Association of India (BDMAI) has announced the unanimous election of AP Rameswara Rao, Chief Promoter & Director of the Rakshit Group of Companies, as its National President. With over 35 years of expertise in manufacturing Bulk Drugs and APIs, Rao
has been a key contributor to India’s pharmaceutical industry growth. A post-graduate in science, he began his career at Vorin Labs (later acquired by Mylan Laboratories), where he pioneered several innovations and was instrumental in the development of Ciprofloxacin HCl. Head to
Alkem Laboratories announced the launch of Pertuza injection 420mg/14mL, a pertuzumab biosimilar, in India for the treatment of HER2-positive breast cancer. Alkem’s Pertuza is an affordable, indigenously developed and manufactured biosimilar of pertuzumab. In the pivotal phase 3
clinical trial, Alkem’s pertuzumab biosimilar, developed by its biotech subsidiary, demonstrated equivalence in efficacy, safety, and immunogenicity to the reference product of the innovator. Head to our website to read more: indiamedtoday.com/alkem-laun…#IndiaMedToday